ARCHIVES

FDA Approves New Indication For Anticoagulant Frangmin

This article is from The Cancer Letter archive.

Vol. 30 No. 5 | May 25, 2007

Download PDF Visit The Full Archive

Related Articles

Physician Bonus Denied Some Agencies; NIH Status Unsure

January 18, 1991

Congress Cuts $210 Million From NIH Budget For The Remainder of 2011

April 15, 2011

New NIH Program To Develop Therapies For Rare, Neglected Diseases

June 19, 2009

ONS Accredited As Approver, Provider Of Continuing Education

April 22, 1988

Revlimid Shows 91 Percent Response in Non-Hodgkin’s

July 29, 2011

Breast Cancer A Heterogeneous Disease, Concepts Changing: Fisher

June 13, 1980